A Multi-Center, Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Study of the Safety and Efficacy of Two Dosing Regimens of QRX-101 (Becocalcidiol) Ointment in the Treatment of Plaque-Type Psoriasis
Latest Information Update: 06 Nov 2021
At a glance
- Drugs Becocalcidiol (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors QUATRx Pharmaceuticals
- 28 May 2014 New trial record